A randomized, double-blind study of larazotide acetate to prevent the activation of celiac disease during gluten challenge.

Leffler, Daniel A

A randomized, double-blind study of larazotide acetate to prevent the activation of celiac disease during gluten challenge. [electronic resource] - The American journal of gastroenterology Oct 2012 - 1554-62 p. digital

Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1572-0241

10.1038/ajg.2012.211 doi


Acute Disease
Adult
Celiac Disease--prevention & control
Double-Blind Method
Female
Gastrointestinal Agents--therapeutic use
Glutens--administration & dosage
Humans
Male
Middle Aged
Oligopeptides--therapeutic use
Secondary Prevention--methods
Severity of Illness Index
Tight Junctions--drug effects